Why did SPL fall 33.3% on 20 Oct 2026?
Starpharma · Pharmaceuticals, Biotechnology & Life Sciences
$10,000 in SPL shares fell to $6,667 that day. It was down as much as 34.7% during the day: about 15 times a usual day's move for SPL, with twice the usual shares traded.
Starpharma's stock fell sharply after it acquired a 66% majority stake in Petalion, with investors likely reacting negatively to the capital deployment and dilution risk associated with this early-stage FAP-targeted cancer program.
No ETF we cover holds Starpharma.
The news
4 of the 4 articles we read name Starpharma. Headlines link to the publisher.
- Starpharma (ASX:SPL) Lifts Petalion Stake to Majority: How Does the FAP-Targeted Program Fit Its DEP Platform?
Kalkine · 20 Oct 2026
- What Does Majority Control of Petalion Mean for Starpharma (ASX:SPL)?
Kalkine Media · 20 Oct 2026
The other 2 articles ›
- Starpharma (ASX:SPL) grabs 66% of Petalion and takes control of a FAP cancer bet
Stocks Down Under · 20 Oct 2026
- What Do Starpharma's (ASX:SPL) FY26 Results Show About the Genentech Payment, Loss and Funding Runway?
Kalkine · 16 Oct 2026
How the model got there ›
Multiple news sources published within hours of the price move confirm Starpharma acquired a controlling 66% stake in Petalion, a FAP-targeted cancer bet. The market reaction is consistent with a 'sell the news' or skeptical response to an early-stage biotech acquisition — concerns about capital deployment, dilution, and strategic fit with the DEP platform are typical triggers for sharp sell-offs in small-cap biotechs. The health sector index was actually up ~0.95% on the day and peers were flat, ruling out sector or macro explanations; the move is clearly stock-specific and timed directly with the Petalion deal news. Confidence is medium rather than high because no formal ASX announcement was found in Layer 1 (suggesting the deal may have been announced just outside the window or via a non-routine filing excluded from the search), so the full terms and any capital raise details are not confirmed.
Company announcements
Starpharma secures majority ownership of Petalion
Web Cast · 20 Oct 2026 · market sensitive
Markets that moved with it · 1
Markets that tend to move with this stock, on the same day or the day before.
- ASX 200 Health CareIts sector · same dayother way+0.95%